ABOUT THIS PODCAST 🔗

Update frequency:
weekly
Average audio length:
14 minutes
Has sponsors
English
United States
153 episodes
since Oct. 5, 2020
episodic

LATEST EPISODE 🔗

Ongoing investments to expand pharmaceutical manufacturing in the U.S. are creating demand for skilled workers, making it increasingly important to strengthen the talent pool to meet industry need. At the same time, competition for experienced engineers, technicians, and other specialized roles is …

SEARCH PAST EPISODES

Search past episodes of Off Script: A Pharma Manufacturing Podcast.

PREVIOUS EPISODES

In biomanufacturing, recovering intracellular bioproducts after fermentation can be a costly and energy-intensive process. To address this challenge, researchers are developing new approaches to reduce energy consumption and waste during downstream processing, one of the largest hidden costs in bio…
Tighter funding conditions are putting greater pressure on emerging biotech to reach key development milestones quickly while managing limited budgets. That environment is also changing what sponsors expect from their manufacturing partners, driving demand for development models that emphasize spee…
Despite ongoing geopolitical and regulatory pressures, life sciences manufacturers continue to invest in their product pipelines while also being more deliberate about long-term portfolio decisions. As interest in peptides, ADCs, and cell and gene therapies continues, manufacturers are weighing the…
Pharmaceutical manufacturers working with hazardous and difficult-to-control chemical reactions face challenges in managing process safety, heat transfer, and reaction conditions. Flow chemistry offers an alternative to traditional batch processing in applications where improved mixing, temperature…
Increased regulatory scrutiny, onshoring efforts, and supply chain vulnerabilities are reshaping how life sciences manufacturers are making investment decisions across the industry. Pharma manufacturers are weighing facility locations, workforce availability, and manufacturing costs while looking f…
Life sciences manufacturers are cautiously optimistic about the potential for emerging technologies like AI, robotics and automation to improve manufacturing operations. While many manufacturers anticipate that these technologies will drive greater operational efficiencies and lower the cost of goo…
Life science manufacturers are investing in expanded production capacity while rethinking facility design and technology strategies to improve efficiency, manage costs, and prepare for the future. Balancing upfront investments with long-term operating costs, while navigating the opportunities of au…
As biopharmaceutical manufacturers work to accelerate facility timelines while managing complex production environments, greater integration between automation, manufacturing systems and other digital technologies is becoming essential. Moving to more connected manufacturing is also driving compani…
While artificial intelligence is expected to transform biopharmaceutical manufacturing, many manufacturers still face challenges in adopting these technologies at scale. Fragmented data, disconnected manufacturing systems and differences in how information is shared across organizations are creatin…
Disclaimer: The podcast and artwork embedded on this page are from Pharma Manufacturing, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.